Sun Pharma to buy 100% stake in Taro in all-cash deal; check details
Sun Pharma News: According to Sun Pharma's filing to the markets, the proposed price reflects a premium of 31.2% over Taro's closing price on May 25, 2023, and a 41.5% premium over Taro's average closing price over the previous 60 days.
Through a reverse triangular merger, Sun Pharmaceutical Industries has proposed to buy out all of Taro Pharmaceutical Industries' shares. Sun Pharma will purchase the shares in the all-cash deal for US $38 per ordinary share, which will be paid in full at the completion of the proposed transaction.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started